Akers Biosciences Inc (AKR)

 

Latest News

Akers Bio revenues up 10%

Akers Biosciences' revenues rose by 10% to $675,831 in the third quarter as as increasing sales of its breathalyzer products an...

3rd Quarter Results

RNS Number: 5093W Akers Biosciences, Inc. 15 November 2017 November 15, 2017 This announcement contains inside information Akers Biosciences, Inc. Financial Results for the Third Quarter Ended September 30, 2017 Revenues up 10% as Breathalyzers and Cholesterol Tests Begin to Contribute Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers," "A...

Akers Bio sees new UK channel for breathalyzer

Akers Biosciences said Accutest Solutions, a distributor of the group's BreathScan alcohol detector in the UK, has secured a...

New UK Channel for Rapid Alcohol Breathalyzer

RNS Number: 3817W Akers Biosciences, Inc. 14 November 2017 November 14, 2017 Akers Biosciences, Inc. UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer Distributor Accutest Now Selling Through Today's Group Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ( " Akers Bio " or the "Company"), a developer of rapid health informatio...

All News

DateHeadlineSource
15-11-17Akers Bio revenues up 10%StockMarketWire
15-11-173rd Quarter ResultsRNS
14-11-17Akers Bio sees new UK channel for breathalyzerStockMarketWire
14-11-17New UK Channel for Rapid Alcohol BreathalyzerRNS
13-11-17Akers schedules results announcementStockMarketWire
13-11-17Notice of ResultsRNS
08-11-17Akers issues sharesStockMarketWire
08-11-17Issue of EquityRNS
20-10-17PDMR Shareholding and Issue of EquityRNS
19-10-17Director/PDMR ShareholdingRNS
13-10-17Warrant Amendment and ExerciseRNS
07-09-17Appointment of U.S. VP of Sales & DistributionRNS
15-08-17Akers Bio revenues up 10%StockMarketWire
15-08-17Half-year ReportRNS
11-08-17Akers Bio in equity issue StockMarketWire
11-08-17Issue of EquityRNS
08-08-17Akers Bio resolutions passed at AGMStockMarketWire
08-08-17Result of AGMRNS
04-08-17Akers Bio second quarter sales jumpStockMarketWire
03-08-17Trading Update and Notice of Q2 ResultsRNS
20-07-17Holding(s) in CompanyRNS
14-07-17Board changes proposed at Akers Biosciences' AGMStockMarketWire
14-07-17Notice of AGM & Directorate ChangesRNS
03-07-17Form S-3 Registration StatementRNS
09-06-17Issue of EquityRNS
16-05-17Akers Biosciences revenue down StockMarketWire
16-05-171st Quarter ResultsRNS
12-05-17Akers Biosciences schedules interimsStockMarketWire
12-05-17Notice of Q1 ResultsRNS
05-05-17Issue of EquityRNS
24-04-17Issue of EquityRNS
11-04-17Holding(s) in CompanyRNS
11-04-17Akers Bio revenues up 40%StockMarketWire
11-04-17Final ResultsRNS
10-04-17Notice of ResultsRNS
10-04-17Issue of EquityRNS
10-04-17Akers Bio marketing HIT rapid test in Puerto RicoStockMarketWire
10-04-17Heparin PF4 Rapid Test in Puerto RicoRNS
07-04-17Akers Bio warrants exercised StockMarketWire
06-04-17Issue of EquityRNS

RSS feeds

  • Editorial news feed for LSE:AKR Editorial
  • Regulatory news feed for LSE:AKR Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account